499 related articles for article (PubMed ID: 15596714)
1. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors.
Shao Y; Gao Z; Marks PA; Jiang X
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18030-5. PubMed ID: 15596714
[TBL] [Abstract][Full Text] [Related]
2. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
Wallace DM; Donovan M; Cotter TG
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
Zhang XD; Gillespie SK; Borrow JM; Hersey P
Mol Cancer Ther; 2004 Apr; 3(4):425-35. PubMed ID: 15078986
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.
Ruefli AA; Ausserlechner MJ; Bernhard D; Sutton VR; Tainton KM; Kofler R; Smyth MJ; Johnstone RW
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10833-8. PubMed ID: 11535817
[TBL] [Abstract][Full Text] [Related]
6. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
7. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway.
Medina V; Edmonds B; Young GP; James R; Appleton S; Zalewski PD
Cancer Res; 1997 Sep; 57(17):3697-707. PubMed ID: 9288776
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
10. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).
Henderson C; Mizzau M; Paroni G; Maestro R; Schneider C; Brancolini C
J Biol Chem; 2003 Apr; 278(14):12579-89. PubMed ID: 12556448
[TBL] [Abstract][Full Text] [Related]
11. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent.
Burek M; Maddika S; Burek CJ; Daniel PT; Schulze-Osthoff K; Los M
Oncogene; 2006 Apr; 25(15):2213-22. PubMed ID: 16288204
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
13. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
14. Suppression of caspase-11 expression by histone deacetylase inhibitors.
Heo H; Yoo L; Shin KS; Kang SJ
Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432
[TBL] [Abstract][Full Text] [Related]
15. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells.
Haydn T; Metzger E; Schuele R; Fulda S
Cell Death Dis; 2017 Jun; 8(6):e2879. PubMed ID: 28617441
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.
Doi S; Soda H; Oka M; Tsurutani J; Kitazaki T; Nakamura Y; Fukuda M; Yamada Y; Kamihira S; Kohno S
Mol Cancer Ther; 2004 Nov; 3(11):1397-402. PubMed ID: 15542778
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
[TBL] [Abstract][Full Text] [Related]
19. The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells.
Ocker M; Alajati A; Ganslmayer M; Zopf S; Lüders M; Neureiter D; Hahn EG; Schuppan D; Herold C
J Cancer Res Clin Oncol; 2005 Jun; 131(6):385-94. PubMed ID: 15754201
[TBL] [Abstract][Full Text] [Related]
20. Synergistic induction of mitochondrial damage and apoptosis in human leukemia cells by flavopiridol and the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA).
Almenara J; Rosato R; Grant S
Leukemia; 2002 Jul; 16(7):1331-43. PubMed ID: 12094258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
